Metasphere Labs Inc. (CSE: LABZ)
Canada
· Delayed Price · Currency is CAD 0.115
+0.005 (4.55%)
Dec 20, 2024, 11:01 AM EST
Metasphere Labs Income Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 |
| Operating Revenue | 1.54 | 2.2 | 0.65 | 7.01 | 0.52 | - |
| Other Revenue | - | - | - | - | 0.01 | 0.02 |
| Revenue | 1.54 | 2.2 | 0.65 | 7.01 | 0.53 | 0.02 |
| Revenue Growth (YoY) | 32.05% | 235.28% | -90.65% | 1211.16% | 2846.28% | - |
| Cost of Revenue | 0.26 | 0.35 | 0.11 | 0.72 | 0.01 | - |
| Gross Profit | 1.29 | 1.84 | 0.55 | 6.28 | 0.53 | 0.02 |
| Selling, General & Admin | 1.17 | 1.04 | 2.81 | 6.19 | 0.22 | 0.01 |
| Research & Development | 0.05 | 0.03 | 0.14 | 1.86 | 0.12 | - |
| Other Operating Expenses | - | - | - | - | 0.01 | - |
| Operating Expenses | 1.22 | 1.17 | 5.81 | 14.23 | 0.35 | 0.01 |
| Operating Income | 0.07 | 0.67 | -5.27 | -7.95 | 0.17 | 0.01 |
| Interest Expense | -0.02 | -0.05 | -0.14 | -0.03 | - | - |
| Interest & Investment Income | 0 | - | 0.02 | - | - | - |
| Currency Exchange Gain (Loss) | - | - | -0 | -0.02 | -0.03 | - |
| Other Non Operating Income (Expenses) | -0.13 | -0.11 | -0.19 | -0.67 | - | - |
| EBT Excluding Unusual Items | -0.07 | 0.51 | -5.58 | -8.68 | 0.14 | 0.01 |
| Merger & Restructuring Charges | - | - | - | -0.38 | - | - |
| Impairment of Goodwill | - | - | -3.32 | - | - | - |
| Gain (Loss) on Sale of Assets | - | - | -0.43 | -0.33 | - | - |
| Asset Writedown | -0.7 | -0.7 | -3.28 | -4.1 | - | - |
| Other Unusual Items | 0.17 | 0.18 | 0.22 | 0.54 | - | - |
| Pretax Income | -0.61 | -0.01 | -12.38 | -12.95 | 0.14 | 0.01 |
| Income Tax Expense | - | - | - | -1.26 | 0.02 | - |
| Earnings From Continuing Operations | -0.61 | -0.01 | -12.38 | -11.68 | 0.13 | 0.01 |
| Earnings From Discontinued Operations | - | - | -0.16 | -0.38 | - | - |
| Net Income | -0.61 | -0.01 | -12.55 | -12.06 | 0.13 | 0.01 |
| Net Income to Common | -0.61 | -0.01 | -12.55 | -12.06 | 0.13 | 0.01 |
| Net Income Growth | - | - | - | - | 981.12% | - |
| Shares Outstanding (Basic) | 27 | 19 | 2 | 1 | - | - |
| Shares Outstanding (Diluted) | 27 | 19 | 2 | 1 | - | - |
| Shares Change (YoY) | 1335.07% | 919.23% | 39.21% | - | - | - |
| EPS (Basic) | -0.02 | -0.00 | -6.88 | -9.21 | - | - |
| EPS (Diluted) | -0.02 | -0.00 | -6.88 | -9.21 | - | - |
| Free Cash Flow | -1.49 | -1 | -2.03 | -1.15 | 0.27 | 0.01 |
| Free Cash Flow Per Share | -0.05 | -0.05 | -1.11 | -0.88 | - | - |
| Gross Margin | 83.45% | 83.97% | 83.22% | 89.68% | 98.32% | 100.00% |
| Operating Margin | 4.66% | 30.73% | -804.59% | -113.52% | 32.09% | 64.35% |
| Profit Margin | -39.50% | -0.65% | -1915.53% | -172.18% | 23.61% | 64.35% |
| Free Cash Flow Margin | -96.25% | -45.39% | -310.18% | -16.44% | 49.80% | 64.35% |
| EBITDA | 0.08 | 0.7 | -5.2 | -7.92 | - | - |
| EBITDA Margin | 5.36% | 31.87% | - | -112.99% | - | - |
| D&A For EBITDA | 0.01 | 0.03 | 0.07 | 0.04 | - | - |
| EBIT | 0.07 | 0.67 | -5.27 | -7.95 | 0.17 | 0.01 |
| EBIT Margin | 4.66% | 30.73% | - | -113.52% | 32.09% | 64.35% |
| Effective Tax Rate | - | - | - | - | 12.08% | - |
| Revenue as Reported | 1.54 | 2.2 | 0.65 | 7.01 | 0.53 | 0.02 |
Source: S&P Capital IQ. Standard template. Financial Sources.